Home
 /
Papers
 /
Biochemistry
 /
ZNFX1 uses two-component ubiquitin circuitry to quarantine viral RNA
Preprint
Open access
V1
Top 1% · Validated by QED

ZNFX1 uses two-component ubiquitin circuitry to quarantine viral RNA

Daniel R. Squair, Eilidh Rivers, Hanna Sowar +10 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.09.05.674436
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Biochemistry this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

This work overturns the mechanistic classification of E3 ubiquitin ligases by showing ZNFX1 bifurcates ubiquitin flux through two distinct routes within one protein, establishing ubiquitin-driven RNA entrapment as a direct antiviral defense underlying human immunodeficiency.

QED claims analysis

Summary

ZNFX1 is an interferon-stimulated RNA helicase with unprecedented bifurcating E3 ubiquitin ligase activity that combines allosteric and transthiolating mechanisms to generate distinct K63- and K48-linked ubiquitin chains, enabling ATP- and RNA-dependent formation of reversible aggregates that entrap and silence viral RNA through a deubiquitination-sensitive mechanism that is essential for antiviral immunity and impaired in patient variants associated with severe immunodeficiency.

See full analysis
Main Claim 1 –

Interferon induces ZNFX1 transthiolating E3 ubiquitin ligase activity

Supporting evidence

  • ZNFX1 C-terminus enables UBE2D-dependent, not UBE2L3, E3 activity
  • Cys1860 is ZNFX1 RZ catalytic cysteine for transthiolation
Main Claim 2 –

ZNFX1 directly restricts RNA virus replication

Supporting evidence

  • ZNFX1 restricts viral RNA and protein independent of interferon signaling
  • Cys1860 supports but is not required for viral restriction
  • Patient ZNFX1 variants impair viral restriction and track disease severity
Main Claim 3 –

ZNFX1 combines allosteric and transthiolating E3 ubiquitin mechanisms

Supporting evidence

  • Transthiolating activity builds K48 chains; allosteric builds K63
  • Dual E3 activities share an F1575-centered E2 binding site
  • ZNFX1 Z-RING is an atypical cross-brace E2-binding domain
  • F1575-mediated E2 binding is required for antiviral restriction
  • ZNFX1 E3 activity drives K48-linked proteasomal turnover
Main Claim 4 –

ATP-dependent RNA binding stimulates ZNFX1 E3 activity

Supporting evidence

  • ZNFX1 helicase residues F1210 and R1216 mediate RNA binding
  • ATP binding enhances RNA binding and enables ZNFX1 E3 activation
  • ATP and RNA act as an AND gate for E3 output
  • ZNFX1 antiviral activity requires both ATP and RNA binding

Abstract

The detection of viral RNA inside cells triggers a diverse range of antiviral responses, including global translation inhibition, interferon secretion and RNA sequestration. Mutations in the gene ZNFX1 cause severe paediatric immunodeficiencies, including chronic viral infection and autoinflammation. Here, we show that ZNFX1 is an RNA helicase with cryptic and unusual bifurcating E3 ubiquitin ligase activity. Nucleotide-dependent RNA binding stimulates ZNFX1 to generate complex ubiquitin chains via a two-component ubiquitin circuit wired in parallel, with ubiquitin flux occurring via either of two competing paths. One route produces K63-linked polyubiquitin that drives ZNFX1 aggregation and RNA entrapment; the other route produces K48-linked polyubiquitin that drives ZNFX1 turnover. RNA entrapment restricts RNA virus replication, and is reversible by deubiquitination. Patient ZNFX1 variants are defective for viral restriction, linking RNA entrapment to antiviral immunity in vivo.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?